APR 13, 2015 06:51 AM PDT

FDA Cites Diabetes Drug For Possible Increased Risk Of Death

WRITTEN BY: Judy O'Rourke
2 28 1318

The agency's review of data on the drug Onglyza, from AstraZeneca, also found an increased risk of hospitalization due to heart failure. [Source: Newsy Science]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
JUL 03, 2018
Videos
JUL 03, 2018
List of Ten Marijuana Falsehoods
Matthew Santoro outlines ten lies about marijuana that are not accurate.
JUL 10, 2018
Videos
JUL 10, 2018
At Four Years Old, This Girl Takes Her First Steps
Cerebral palsy (CP) is a neurological condition that is usually present at birth. It’s common in children born prematurely. For one little girl, Maya
JUL 11, 2018
Videos
JUL 11, 2018
College Football Player Who Committed Suicide Had CTE
Chronic Traumatic Encephalopathy (CTE) is the talk of professional sports. From NFL players to ice hockey veterans, rugby teams, and soccer organizations,
JUL 22, 2018
Videos
JUL 22, 2018
No language needed
If you don’t have language, how do you think? If you know fewer words, can you think fewer thoughts? Or perhaps less complex thoughts? That’s t
AUG 02, 2018
Videos
AUG 02, 2018
CBD and THC Effects on the Brain
What has similar chemical make-ups but different structures? CBD and THC. In the video below, learn more about how THC (tetrahydrocannabinol) and CBD (Cann
AUG 08, 2018
Videos
AUG 08, 2018
A Harbinger of Hope for Alzheimer's Patients?
The search for effective treatments for Alzheimer’s disease is ongoing, but overall, hasn’t been productive. Many companies, like pharmaceutica
Loading Comments...